Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0033774 (
pruritus
)
14,546
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
We report a study of eight unrelated adult patients with a highly distinctive phenotype of dystrophic
epidermolysis bullosa
. It is characterized clinically by
pruritus
, lichenified or nodular prurigo-like lesions, violaceous linear scarring, occasional trauma-induced blistering, excoriations, milia, nail dystrophy and, in some cases, albopapuloid lesions on the trunk. The scarring is most evident on the limbs, particularly on the shins, with relative sparing elsewhere. Intact blisters are rarely seen. Physical signs were present at birth in three patients, but in the others skin manifestations were first noticed between 6 months and 10 years of age. Five cases are sporadic, but three of the eight patients have a history of familial involvement, with autosomal dominant inheritance in two cases and recessive transmission in the other case. Studies of the dermal-epidermal junction showed alterations in the number and ultrastructure of anchoring fibrils in lesional, perilesional and non-lesional skin, consistent with a diagnosis of dominant or localized recessive dystrophic
epidermolysis bullosa
. These patients represent an unusual, poorly recognized form or expression of dystrophic
epidermolysis bullosa
which has features in common with a variety of acquired inflammatory dermatoses.
...
PMID:Epidermolysis bullosa pruriginosa: dystrophic epidermolysis bullosa with distinctive clinicopathological features. 929 92
We report a family suffering from dominant dystrophic
epidermolysis bullosa
, in whom linear lichenified lesions and troublesome
pruritus
were prominent features. We consider that this clinical picture may constitute a separate subtype of this disorder.
...
PMID:Linear prurigo simulating dermatitis artefacta in dominant dystrophic epidermolysis bullosa. 821 60
A 46-year-old woman with the Dowling-Meara variant of
epidermolysis bullosa
simplex (DM-EBS) presented with worsening recurrent, pruritic, circinate crops of clear and haemorrhagic herpetiform blisters affecting her trunk and limbs. Electron microscopy showed tonofilament aggregation and an intra-epidermal level of blister formation confirming a diagnosis of DM-EBS rather than an acquired immunobullous disorder. Antihistamines failed to control the intense
pruritus
, but dapsone (up to 150 mg daily) was beneficial. Mutations of basal cell keratin genes (K14 and K5) are thought to be of aetiopathological significance in this form of
epidermolysis bullosa
, but the underlying cellular mechanisms responsible for the clinical deterioration and severe
itching
in this adult patient are not yet clear.
...
PMID:Epidermolysis bullosa simplex Dowling-Meara: troublesome blistering and pruritus in an adult patient. 843 22
Epidermolysis bullosa pruriginosa is a recently recognized variant of dystrophic
epidermolysis bullosa
(DEB) characterized by severe
pruritus
and scarring, mainly involving the extensors of the extremities. In this study, we searched for mutations in the type VII collagen gene (COL7A1) using polymerase chain reaction amplification of exonic segments of COL7A1, followed by heteroduplex analysis, in a Chinese pedigree with dominant DEB displaying a striking anastomosing network of lichenoid papules and scarring. The study revealed a G-to-A transition at nucleotide 6724 within exon 85 of COL7A1, converting a glycine to an arginine (G2242R) within the triple-helical domain of the type VII collagen in affected individuals. These findings demonstrate that EB pruriginosa in this family is a clinical variant of dominant DEB.
...
PMID:A glycine-to-arginine substitution in the triple-helical domain of type VII collagen in a family with dominant dystrophic epidermolysis bullosa pruriginosa. 918 28
Epidermolysis bullosa
(EB) pruriginosa is a rare clinical subset of dystrophic EB, characterized by marked
itching
and presence of prurigo-like or lichenoid features. In order to further delineate the phenotype and understand the pathogenesis of this disorder, the clinical, histological and ultrastructural findings of a 19-year-old patient presenting a typical form of EB pruriginosa are described. The prevalence of papular itchy lichenoid lesions, signs of scratching and paucity of blisters at the time of clinical examination may result in incorrect diagnosis and treatment. Microscopic studies of the lesions show the typical findings of dystrophic EB associated with an unusually high density of collagen bundles and absence of elastic fibres in the upper dermis.
Itching
lichenoid lesions of EB pruriginosa could represent an abnormal dermal reactivity of some patients to their inherited bullous disorder.
...
PMID:Epidermolysis bullosa pruriginosa. 926 44
A 39-year-old woman had a three-year history of recurrent bullous eruption localized to her left cheek. The diagnosis of
epidermolysis bullosa
acquisita was confirmed by means of direct immunofluorescence and direct immunoelectron microscopic studies performed on the perilesional salt-split skin. Topical corticosteroid treatment reduced
pruritus
and bullae formation. This case of localized
epidermolysis bullosa
acquisita on the face is reminiscent of Brunsting-Perry cicatricial pemphigoid. We also review the previously reported cases of localized
epidermolysis bullosa
acquisita.
...
PMID:Epidermolysis bullosa acquisita localized to the face. 951 4
We describe a patient with sporadic dystrophic
epidermolysis bullosa
associated with well-documented atopic dermatitis. We discuss this case in relation to a newly described clinical subtype of
epidermolysis bullosa
known as
epidermolysis bullosa
pruriginosa, a dystrophic variant associated with prominent
pruritus
. The relations of this case of sporadic dystrophic
epidermolysis bullosa
with other dominantly inherited forms of dystrophic
epidermolysis bullosa
such as the Pasini variant, the pretibial variant, and Bart's syndrome are also discussed. The role of atopic dermatitis in exacerbating dystrophic
epidermolysis bullosa
in this patient raises an important consideration in the care of this group of patients.
...
PMID:Sporadic dystrophic epidermolysis bullosa with concomitant atopic dermatitis. 960 82
A 12 y old girl with the albopapuloid variant (Pasini) of dominant dystrophic
epidermolysis bullosa
is studied. The albopapuloid lesions developed within the first year of life, contained milia and were associated with
pruritus
. Mutation detection of the COL7A1 gene revealed a G-->A transition at nucleotide position 6110 in the mutant allele converting a glycine to glutamic acid (G2037E). This report adds to the expanding database on COL7A1 mutations in dystrophic
epidermolysis bullosa
.
...
PMID:Dominant dystrophic epidermolysis bullosa (Pasini) caused by a novel glycine substitution mutation in the type VII collagen gene (COL7A1). 1023 77
Three patients in two families presented with many years' history of fragile skin, blisters, erosions and scars affecting almost exclusively the shin areas, accompanied by a variable degree of
itching
. Two of the patients also had toenail dystrophy. Skin biopsy revealed dermal-epidermal blister formation and milia but no immunohistochemical evidence of immunoglobulin or complement deposition. Electron microscopic study of the lesional and perilesional skin showed very sparse or absent anchoring fibrils. Immunolabelling for type VII collagen using LH 7.2 monoclonal antibody revealed a bright, linear staining pattern at the dermal-epidermal junction. The clinicopathological features were thus compatible with pretibial
epidermolysis bullosa
, a subtype of dystrophic
epidermolysis bullosa
. Of note, the inflammatory nature of the skin lesions, and their resemblance to nodular prurigo and hypertrophic lichen planus, had caused diagnostic difficulties in all cases in the past. A high degree of awareness of this rare subtype of
epidermolysis bullosa
is important to establish the correct diagnosis, to allow for genetic counselling and to plan clinical management.
...
PMID:Three Hong Kong Chinese cases of pretibial epidermolysis bullosa: a genodermatosis that can masquerade as an acquired inflammatory disease. 1035 66
The inherited mechanobullous disease, dystrophic
epidermolysis bullosa
, is caused by type VII collagen gene (COL7A1) mutations. We studied six unrelated patients with a distinct clinical subtype of this disease,
epidermolysis bullosa
pruriginosa, characterized by
pruritus
, excoriated prurigo nodules, and skin fragility. Mutation analysis using polymerase chain reaction amplification of genomic DNA, heteroduplex analysis and direct nucleotide sequencing demonstrated pathogenetic COL7A1 mutations in each case. Four patients had a glycine substitution mutation on one COL7A1 allele (G1791E, G2242R, G2369S, and G2713R), a fifth was a compound heterozygote for a splice site mutation (5532 + 1G-to-A) and a single base pair deletion (7786delG), and a sixth patient was heterozygous for an out-of-frame deletion mutation (6863del16). This study shows that the molecular pathology in patients with the distinctive clinical features of
epidermolysis bullosa
pruriginosa is heterogeneous and suggests that other factors, in addition to the inherent COL7A1 mutation(s), may be responsible for an
epidermolysis bullosa
pruriginosa phenotype.
...
PMID:Allelic heterogeneity of dominant and recessive COL7A1 mutations underlying epidermolysis bullosa pruriginosa. 1038 49
1
2
3
4
5
6
Next >>